Pancreatic Cancer Research

ResearcherSecond Affiliated Hospital of Zhejiang UniversityNo recent work listed

Jianying Lou

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8625-9026; OpenAlex author ID A5003319267. Sources: OpenAlex.

Their work

Papers
6 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
22
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: none · 2019: 3 papers · 2020: 1 paper · 2021: 1 paper

Papers 6

  1. Hypoxia promotes pancreatic cancer cell migration, invasion, and epithelial-mesenchymal transition via modulating the FOXO3a/DUSP6/ERK axis. Last author DOI 10.21037/jgo-21-359↗
  2. Systematic Analysis of Alternative Splicing Landscape in Pancreatic Adenocarcinoma Reveals Regulatory Network Associated with Tumorigenesis and Immune Response. Co-author DOI 10.12659/msm.925733↗
  3. Vimentin-positive circulating tumor cells as a biomarker for diagnosis and treatment monitoring in patients with pancreatic cancer. Co-author DOI 10.1016/j.canlet.2019.03.009↗
  4. Monitoring Tumor Burden in Response to FOLFIRINOX Chemotherapy Via Profiling Circulating Cell-Free DNA in Pancreatic Cancer. Co-author DOI 10.1158/1535-7163.mct-17-1298↗
  5. Association of Modified-FOLFIRINOX-Regimen-Based Neoadjuvant Therapy with Outcomes of Locally Advanced Pancreatic Cancer in Chinese Population. Co-author DOI 10.1634/theoncologist.2018-0696↗
  6. [Modified FOLFIRINOX for advanced pancreatic cancer: a tertiary center experience from China]. Co-author DOI 10.3760/cma.j.issn.0529-5815.2016.04.006↗

Closest collaborators

The 22 strongest of 22 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Risheng Que · 4 shared papers, 2016–2019 · strength 0.29
  2. Tingbo Liang · 4 shared papers, 2016–2019 · strength 0.29
  3. Xiang Li · 3 shared papers, 2019 · strength 0.24
  4. Hua Zhao · 1 shared paper, 2021 · strength 0.19
  5. Tao Ma · 2 shared papers, 2019 · strength 0.16
  6. Lei Zheng · 2 shared papers, 2019 · strength 0.16
  7. Xueli Bai · 2 shared papers, 2019 · strength 0.16
  8. Guogang Li · 2 shared papers, 2016–2019 · strength 0.14
  9. Qichun Wei · 2 shared papers, 2016–2019 · strength 0.13
  10. Xueli Bai · 2 shared papers, 2016–2019 · strength 0.13
  11. Ri‐Sheng Yu · 2 shared papers, 2016–2019 · strength 0.13
  12. Jiahua Lu · 1 shared paper, 2020 · strength 0.13
  13. Shusen Zheng · 1 shared paper, 2020 · strength 0.13
  14. Tao Wei · 1 shared paper, 2019 · strength 0.09
  15. Qi Chen · 1 shared paper, 2019 · strength 0.08
  16. Ying Yuan · 1 shared paper, 2019 · strength 0.08
  17. Qi Zhang · 1 shared paper, 2019 · strength 0.08
  18. Yiwen Chen · 1 shared paper, 2019 · strength 0.08
  19. Tao Wei · 1 shared paper, 2019 · strength 0.08
  20. Pintong Huang · 1 shared paper, 2019 · strength 0.08
  21. Jiaqi Yang · 1 shared paper, 2019 · strength 0.08
  22. Yinan Shen · 1 shared paper, 2019 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.